Coumadin alone or aspirin plus coumadin reduced coronary events and death after acute myocardial infarction or unstable angina

Hudson, Michael P.
January 2003
ACP Journal Club;Jan/Feb2003, Vol. 138 Issue 1, p9
Academic Journal
Focuses on a study which investigated the role of coumadin or aspirin plus coumadin in reducing coronary events and death after acute myocardial infarction or unstable angina. Assessment of the clinical characteristics of patients; Patient intervention; Outcome measures.


Related Articles

  • HEART TEAMWORK.  // Prevention;Jan89, Vol. 41 Issue 1, p14 

    Reports on research results which indicate that combining streptokinase and aspirin reduces heart attack deaths. Importance of quick administration of the treatment; Decreased chances of death if therapy is used within four hours after the first heart attack symptom; Reduced death rate even if...

  • Warfarin, acetylsalicylic acid or both? Hoey, John // CMAJ: Canadian Medical Association Journal;10/29/2002, Vol. 167 Issue 9, p1036 

    Examines drug therapies used in treatment of myocardial infarction including warfarin, acetylsalicylic acid (ASA), or aspirin, or both. Results of tests involving patients in all three drug therapies; Conclusions based on results show mortality across all three therapies were identical.

  • Stopping aspirin raises CVD mortality risk.  // Pulse;8/10/2011, Vol. 71 Issue 26, p8 

    The article reports that Spanish researchers have found that cessation of aspirin use as secondary prevention for cardiovascular disease can increase the risk of heart attack or coronary heart disease by 50%.

  • Can Inflammation Really Trigger a Heart Attack? Ferraro, Julia // RN;Jul97, Vol. 60 Issue 7, p14 

    Asks the question if inflammation can trigger a heart attack. Details of a study conducted; How aspirin reduced the risk of heart attack.

  • My Heart Attack. Abatemarco, Fred // Men's Health;Sep2002, Vol. 17 Issue 7, p152 

    Presents a guide on how to deal with heart attacks. Importance of staying physically fit; Benefits of chewing an aspirin; Information on angioplasty.

  • Triflusal: A Viewpoint by Wilbert S. Aronow. Aronow, W.S. // Drugs;Jun1998, Vol. 55 Issue 6, p834 

    Discusses clinical trials comparing the platelet antiaggregant triflusal with aspirin or placebo. Benefit of aspirin in reducing myocardial infarction, stroke or vascular death.

  • Aspirin for all over 50 revisited. Elwood, Peter; Morgan, Gareth // Heart;Nov2008, Vol. 94 Issue 11, p1364 

    The article reports on a study of the risks of aspirin prophylaxis among diabetic patients with ages ranging between 30 to 74 years. It states that vascular risk of aspirin prophylaxis is estimated to people whose age is 48 years old for men and 57 years old for women. It also mentions that...

  • NICE guidance on clopidogrel.  // GP: General Practitioner;5/10/2004, p12 

    Draft guidance on the use of clopidogrel (Plavix) in the management of non-ST segment elevation acute coronary syndrome (ACS) has been issued by NICE. It recommends the use of clopidogrel, in combination with low-dose aspirin, for patients who have non-ST segment elevation ACS and have a...

  • Does Aspirin Protect Women The Way It Protects Men? Keener, Marchada // RN;May2005, Vol. 68 Issue 5, p25 

    The article reports that the recently completed Women's Health Study found that women who take a low dose of aspirin regularly can significantly reduce their risk of stroke. Aspirin does not, however, appear to protect women from a first heart attack, as it has been shown to do in men. In...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics